Contribution of positron emission tomography in pleural disease - 19/10/10
, J.-L. Corhay a, M.-P. Larock b, N. Withofs b, T. Bury a, R. Hustinx b, R. Louis a
Corresponding author. Immunity and inflammation research group, Division pulmonary medicine, CHU Sart-Tilamn, 4000 Liege, Belgium.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Summary |
Introduction |
Positron emission tomography (PET) now plays a clear role in oncology, especially in chest tumours. We discuss the value of metabolic imaging in characterising pleural pathology in the light of our own experience and review the literature.
Background |
PET is particularly useful in characterising malignant pleural pathologies and is a factor of prognosis in mesothelioma. Metabolic imaging also provides clinical information for staging lung cancer, in researching the primary tumour in metastatic pleurisy and in monitoring chronic or recurrent pleural pathologies.
Conclusions |
PET should therefore be considered as a useful tool in the diagnosis of liquid or solid pleural pathologies.
El texto completo de este artículo está disponible en PDF.Keywords : Positron emission tomography, Pleurisy, Pleural mesothelioma, Pleural metastasis, Lung cancer
Esquema
 | To cite the present paper, use exclusively the following reference: Duysinx B, Corhay JL, Larock MP, Withofs N, Bury T, Hustinx R, et al. Apport de l’imagerie par tomographie à émission de positons dans la pathologie pleurale (full text in english on www.emconsulte/. com/revue/rmr). Rev Mal Respir 2008;25:129–38. Doi: RMR-02-2008-25-2-01761-8425-101019-200802944. |
Vol 27 - N° 8
P. e47-e53 - octobre 2010 Regresar al número
Artículo precedente
- Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients
- J.-P. Gangneux, C. Camus, B. Philippe
- Inhaled insulin: A model for pulmonary systemic absorption?
- M.-H. Becquemin, J.-P. Chaumuzeau